Dynavax is kicking off May’s Hepatitis Awareness Month with a new push to improve education around hepatitis B and the ...

Discover an awarding winning abstract from EASL 2025 that has called for more person-centred hepatitis screening. Learn more.

An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV ... bepirovirsen as a monotherapy in the first half of next year, and is also exploring use ...

SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, ...

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV ... 3 programme due to start in the first half of 2023. Hepatitis B affects almost ...

Net Loss: For the first quarter of 2025, the Company generated a net loss attributable to its shareholders of $19.6 million, ...

Both those infected by contaminated blood products and those affected by the scandal - such as partners, parents, children ...

One participant with a history of hepatitis C, hepatitis B, human immunodeficiency virus infection ... 168 hours of washout for extended half-life recombinant factor IX before factor IX sample ...

A number of images from different angles ... Helen Branswell writes today about how the loss of the CDC’s viral hepatitis lab will leave the country with no good way to measure the scale ...

(Photo Credit: Science Photo Library/Getty Images) Juan Pablo Arab ... liver infection and liver cancer. About half of the people with hepatitis B don’t realize they have it.